Skip to content

Saturday, May 4, 2024

Latest:

Image of the Month: Faces of embryo development
Wearable technology gives surgeons data to improve posture during surgery
Uncovering the secret of long-lived stem cells
Headed to a festival or outdoor event soon? Here is what you should know
Healthcare on wheels: Using mobile clinics to reach children all over Houston

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

cancer inhibitor

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs Image of the Month:

From the Labs: Faces of embryo development.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951